Airsculpt Technologies, Inc. Stock Price, News & Analysis

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a robust first quarter for 2022, with cases increasing by 31.1% to 3,156, and revenue soaring by 51.3% to $39.5 million. The company noted significant growth in same-center metrics, with cases up 12.2% and revenue per case up 14.6%. However, a net loss of $(0.7) million was reported, compared to a net income of $6.6 million last year. Adjusted EBITDA slightly increased to $9.8 million. The company has raised its full-year revenue outlook to between $175-$179 million.

AirSculpt Technologies (NASDAQ: AIRS) will announce its first quarter results on May 13, 2022, before the market opens. A conference call will follow at 8:30 a.m. Eastern Time, accessible via phone or webcast. Investors can participate by calling 1-877-407-9716 for US calls, or 1-201-493-6779 for international calls. A replay will be available shortly after the call. AirSculpt specializes in body contouring procedures under the Elite Body Sculpture brand, utilizing their proprietary AirSculpt® method for effective fat removal.

AirSculpt Technologies (NASDAQ:AIRS) reported strong financial results for Q4 and full year 2021. Q4 case volume grew by 43.8% to 2,885, with revenue increasing 64.4% to $37.6 million. For the full year, cases rose 87.8% to 11,050 and revenue jumped 112.4% to $133.3 million. Notably, adjusted EBITDA reached $46.1 million, marking a 163.5% increase. However, the company recorded a net loss of $14.2 million in Q4 compared to a net income of $5.6 million last year. For 2022, revenue is projected to rise by 29% to 32%. The company maintains a solid liquidity position with $25.3 million in cash.

AirSculpt Technologies (NASDAQ: AIRS) will release its fourth quarter and full year results on March 11, 2022, before the market opens. A conference call will follow at 8:30 a.m. ET, accessible via phone or webcast. The company specializes in minimally invasive body contouring procedures, offering the proprietary AirSculpt® method for fat removal. This announcement may provide investors with insights into financial performance and future outlook.

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a strong Q3 2021, with a 60.4% increase in case volume to 2,743 and a 94.3% rise in revenue to $34.7 million. Net income reached $8.1 million, up from $2.9 million a year ago. Adjusted EBITDA surged 127.2% to $12.1 million. Year-to-date, revenue jumped 139.9% to $95.8 million with a projected full-year revenue of $130 million. The company continues to expand, opening new centers in Miami Beach and Salt Lake City, bringing the total to 18.

AirSculpt Technologies has announced the opening of two new body contouring centers in Miami Beach, Florida, and Salt Lake City, Utah, increasing its total to 18 locations across 14 states. CEO Dr. Aaron Rollins emphasized this expansion as part of their de novo strategy to meet growing consumer demand for their AirSculpt® technology. The Miami center, located at 1111 Lincoln Road, will also serve as a training hub. AirSculpt aims to make its innovative services accessible to major cities nationwide, reflecting its commitment to premium consumer experiences.

AirSculpt Technologies (NASDAQ: AIRS) announced it will release its Q3 results on December 3, 2021, before market open, followed by a conference call at 8:30 a.m. ET. Investors can dial in at 1-877-407-9716 for the live call or access a replay using the code 13725116. The replay will be available until December 10, 2021. AirSculpt specializes in body contouring procedures through its proprietary AirSculpt® method, focusing on delivering a high-quality consumer experience.

AirSculpt Technologies has announced its initial public offering (IPO) of 7,000,000 shares at $11.00 per share. The offering consists of 2,173,913 shares issued by the company and 4,826,087 shares sold by existing stockholders. Underwriters have a 30-day option to buy an additional 1,050,000 shares. The shares are set to trade on NASDAQ under the symbol AIRS on October 29, 2021, with expected closing on November 2, 2021.

AirSculpt Technologies has announced the commencement of its initial public offering (IPO) roadshow, aiming to raise funds by offering 1,562,500 shares of common stock, alongside 8,437,500 shares from existing stockholders. The IPO price is set between $15.00 and $17.00 per share, with an option for underwriters to purchase up to 1,500,000 additional shares. The company intends to list its stock on Nasdaq under the symbol 'AIRS'. Morgan Stanley and Piper Sandler are leading the offering, with a registration statement already filed with the SEC but not yet effective.